13F

Stock

Crispr Therapeutics Ag

CRSP · held by 5 managers

Reported value

$7.73M

Holders

5

+2 new · −0 exited

Holders’ est. mark

−$677.1K

Price effect on 3 books still in the name

Largest holder

$6.1M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC129.8K$6.1M−$461.3KAdded$2.56M
Marex Group plc22.3K$1.05M−$144.7KCut−$62.9K
Norris Financial Group, LLC10.4K$486.4K−$71.1KCut−$59.8K
DANSKE BANK A/S1.6K$75.2KNew
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main460$21.6KNew

Positions as of Q3 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.